Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0014 | 0.2065 | 0.5 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.3253 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trichomonas vaginalis | taga, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Entamoeba histolytica | hypothetical protein | 0.0018 | 0.3253 | 0.1498 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.004 | 1 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.2065 | 0.2065 |
Entamoeba histolytica | multidrug resistance protein, putative | 0.0018 | 0.3253 | 0.1498 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0014 | 0.2065 | 0.5 |
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.0018 | 0.3253 | 0.3253 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.3253 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2065 | 0.2065 |
Echinococcus multilocularis | multidrug resistance associated protein 4 | 0.0011 | 0.1114 | 0.1114 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.3253 | 0.2407 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.0018 | 0.3253 | 0.1498 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Onchocerca volvulus | 0.0014 | 0.2065 | 0.5 | |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.004 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1498 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0014 | 0.2065 | 0.0994 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.004 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1498 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3179 | 0.2259 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.004 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.2065 | 0.0994 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1498 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2065 | 0.2065 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.004 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1498 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Giardia lamblia | MRP-like ABC transporter | 0.0018 | 0.3253 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 4 | 0.0011 | 0.1114 | 0.1114 |
Brugia malayi | ABC transporter transmembrane region family protein | 0.0018 | 0.3253 | 0.1498 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0014 | 0.199 | 0.199 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.004 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.004 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0014 | 0.199 | 0.199 |
Entamoeba histolytica | ABC transporter, putative | 0.0018 | 0.3253 | 0.1498 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.0018 | 0.3253 | 0.2407 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.0018 | 0.3253 | 0.3253 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.004 | 1 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2065 | 0.2065 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.004 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1498 |
Leishmania major | pentamidine resistance protein 1 | 0.0018 | 0.3253 | 0.1498 |
Leishmania major | p-glycoprotein e | 0.0018 | 0.3253 | 0.1498 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.004 | 1 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.004 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.199 | 0.091 |
Leishmania major | ABC-thiol transporter | 0.0018 | 0.3253 | 0.1498 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1498 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.0018 | 0.3253 | 0.1498 |
Brugia malayi | multidrug resistance related protein 1 | 0.0018 | 0.3253 | 0.1498 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0014 | 0.2065 | 0.0994 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2065 | 0.2065 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.0018 | 0.3253 | 0.1498 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3253 | 0.2343 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2065 | 0.2065 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.3253 | 0.2407 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.004 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1498 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2065 | 0.2065 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.0018 | 0.3253 | 0.2343 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2065 | 0.2065 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.0018 | 0.3253 | 0.3253 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.004 | 1 | 1 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.0018 | 0.3253 | 0.3253 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1498 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.004 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3253 | 0.2343 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.004 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.2065 | 0.0994 |
Giardia lamblia | ABC transporter, putative | 0.0018 | 0.3253 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2065 | 0.2065 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0018 | 0.3253 | 0.1498 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.0018 | 0.3253 | 0.1498 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.004 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2065 | 0.2065 |
Trypanosoma brucei | trans-sialidase | 0.003 | 0.6974 | 0.5515 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 64 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.